• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients
ConclusionsThe use of a blood biomarker test to guide pre-hospital thrombolysis is cost-effective compared with standard hospital care in patients with ischemic stroke.
Source: The European Journal of Health Economics - July 27, 2022 Category: Health Management Source Type: research

Evaluating the cost-utility of a direct transfer to angiosuite protocol within 6  hours of symptom onset in suspected large vessel occlusion patients
CONCLUSIONS: Our economic model predicts that the implementation of a DTAS program is cost-effective compared to no organizational changes. Our model also predicts better clinical outcomes for patients in terms of functional independence and quality-adjusted life years.PMID:35960180 | DOI:10.1080/13696998.2022.2113221
Source: Journal of Medical Economics - August 12, 2022 Category: Health Management Authors: Manuel Requena Valeska Seguel Andreu Vilaseca-Jolonch Jacklyn Woods Pablo Guijarro Marc Ribo Alejandro Tomasello Carlos A Molina Source Type: research